Hjem › Neoplasmer etter histologisk type › Georgia
Kliniske studier for Neoplasmer etter histologisk type i Georgia
6 studier for Neoplasmer etter histologisk type søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Emory University Hospital, Atlanta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07075185Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Emory Healthcare - The Emory Clinic, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06001788A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Winship Cancer Institute of Emory University, Atlanta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04104776Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Winship Cancer Institute - Emory University, Atlanta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT04198766A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University Cancer and Blood Center, Athens
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
- Northside Hospital, Atlanta
RekruttererFase 1
Alder 18 til 75 · Alle kjønn · Oppdatert 2. aug. 2024 · NCT06271252Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.